+250.7%
TQQQ vs GSK
+47.2%
+203.5%
-58.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.6% | 0.0% | +2.5% | +2.6% |
| 7D | -1.9% | -3.5% | +1.6% | -1.5% |
| 30D | -4.9% | -3.4% | -1.4% | -4.5% |
| 3M | -6.4% | -8.1% | +1.7% | -5.6% |
| 6M | +44.4% | -11.1% | +55.5% | +46.5% |
| YTD | +35.2% | +0.7% | +34.4% | +33.7% |
| 1Y | +49.5% | +20.1% | +29.4% | +42.0% |
| 3Y | +250.7% | +46.1% | +204.6% | +222.4% |
| All | +250.7% | +47.2% | +203.5% | +222.4% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling